mination Pathways as Novel Therapeutics ? • Complement inhibitors and blocking antibodies • Microglial phagocytic receptors • Early Biomarkers? Broader Relevance for Other CNS Disorders? EFTA00799263 A Common Mechanism of Synapse Loss and Cognitive Dysfunction? Reactive astrocyte Alzheimer's Disease Gla